Powder: -20°C for 3 years | In solvent: -80°C for 1 year
L-2-Phosphoglyceric acid disodium salt hydrate 是一种甘油酸,可作为糖酵解第九步的底物。它被烯醇化酶催化为磷酸烯醇式丙酮酸 (PEP),这是葡萄糖转化为丙酮酸的倒数第二个步骤。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 750 | 待询 | ||
2 mg | ¥ 1,000 | 待询 | ||
5 mg | ¥ 1,718 | 待询 | ||
10 mg | ¥ 2,800 | 待询 | ||
25 mg | ¥ 4,750 | 待询 | ||
50 mg | ¥ 7,656 | 待询 |
L-2-Phosphoglyceric acid disodium salt hydrate 的其他形式现货产品:
产品描述 | 2-Phosphoglyceric acid (2PGA) is a glyceric acid which serves as the substrate in the ninth step of glycolysis. It is catalyzed by enolase into phosphoenolpyruvate (PEP), the penultimate step in the conversion of glucose to pyruvate. |
体内活性 | SRT1720 (10, 30, 100 mg/kg, p.o.) significantly reduces the hyperinsulinemia after 4 weeks, partially normalizing elevated insulin levels similar to rosiglitazone treatment. SRT1720 treatment significantly reduces fasting blood glucose to near normal levels in Lepob/ob mice[1]. SRT1720 has the ability to protect against the negative effects of diet-induced obesity in mice and has a connection to metabolic adaptation in fatty acid and oxidative metabolism through downstream targets of SIRT1 such as PGC1α and FOXO1[2]. SRT1720 (50-100 mg/kg, p.o.), during emphysema development, attenuates elastase-induced airspace enlargement and lung function impairment as well as reduces arterial oxygen saturation in WT mice [3]. |
别名 | L-2-Phosphoglyceric acid 二钠盐水合物 |
分子量 | 230.02 |
分子式 | C3H5Na2O7P · xH2O |
CAS No. | T5141 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.3474 mL | 21.7372 mL | 43.4745 mL | 108.6862 mL |
5 mM | 0.8695 mL | 4.3474 mL | 8.6949 mL | 21.7372 mL | |
10 mM | 0.4347 mL | 2.1737 mL | 4.3474 mL | 10.8686 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
L-2-Phosphoglyceric acid disodium salt hydrate T5141 Others L2Phosphoglyceric acid disodium salt hydrate L-2-Phosphoglyceric acid 二钠盐水合物 L 2 Phosphoglyceric acid disodium salt hydrate L-2-Phosphoglyceric acid disodium Hydrate Inhibitor inhibitor inhibit